Logo image of IMR.CA

IMETAL RESOURCES INC (IMR.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:IMR - CA45250A4063 - Common Stock

0.115 CAD
+0.01 (+4.55%)
Last: 1/13/2026, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, IMR scores 2 out of 10 in our fundamental rating. IMR was compared to 813 industry peers in the Metals & Mining industry. The financial health of IMR is average, but there are quite some concerns on its profitability. IMR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year IMR has reported negative net income.
  • In the past year IMR has reported a negative cash flow from operations.
  • IMR had negative earnings in each of the past 5 years.
  • IMR had a negative operating cash flow in each of the past 5 years.
IMR.CA Yearly Net Income VS EBIT VS OCF VS FCFIMR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M

1.2 Ratios

  • IMR has a Return On Assets (-20.48%) which is comparable to the rest of the industry.
  • IMR has a Return On Equity of -23.72%. This is comparable to the rest of the industry: IMR outperforms 55.60% of its industry peers.
Industry RankSector Rank
ROA -20.48%
ROE -23.72%
ROIC N/A
ROA(3y)-28.13%
ROA(5y)-30.94%
ROE(3y)-32.31%
ROE(5y)-34.35%
ROIC(3y)N/A
ROIC(5y)N/A
IMR.CA Yearly ROA, ROE, ROICIMR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • IMR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMR.CA Yearly Profit, Operating, Gross MarginsIMR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

5

2. Health

2.1 Basic Checks

  • IMR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for IMR has been increased compared to 5 years ago.
  • There is no outstanding debt for IMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMR.CA Yearly Shares OutstandingIMR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
IMR.CA Yearly Total Debt VS Total AssetsIMR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -6.39, we must say that IMR is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -6.39, IMR is not doing good in the industry: 69.25% of the companies in the same industry are doing better.
  • IMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.39
ROIC/WACCN/A
WACCN/A
IMR.CA Yearly LT Debt VS Equity VS FCFIMR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that IMR should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, IMR is in line with its industry, outperforming 44.16% of the companies in the same industry.
  • IMR has a Quick Ratio of 1.26. This is a normal value and indicates that IMR is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.26, IMR perfoms like the industry average, outperforming 46.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
IMR.CA Yearly Current Assets VS Current LiabilitesIMR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M

0

3. Growth

3.1 Past

  • IMR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.01%, which is quite impressive.
EPS 1Y (TTM)60.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

  • IMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMR.CA Price Earnings VS Forward Price EarningsIMR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMR.CA Per share dataIMR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • IMR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

IMETAL RESOURCES INC

TSX-V:IMR (1/13/2026, 7:00:00 PM)

0.115

+0.01 (+4.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-27
Earnings (Next)01-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.96%
Ins Owner ChangeN/A
Market Cap4.16M
Revenue(TTM)N/A
Net Income(TTM)-1.62M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.48%
ROE -23.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-28.13%
ROA(5y)-30.94%
ROE(3y)-32.31%
ROE(5y)-34.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z -6.39
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)35131.1%
Cap/Depr(5y)24285.8%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-92.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-73.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.73%
OCF growth 3YN/A
OCF growth 5YN/A

IMETAL RESOURCES INC / IMR.CA FAQ

What is the ChartMill fundamental rating of IMETAL RESOURCES INC (IMR.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IMR.CA.


Can you provide the valuation status for IMETAL RESOURCES INC?

ChartMill assigns a valuation rating of 0 / 10 to IMETAL RESOURCES INC (IMR.CA). This can be considered as Overvalued.


What is the profitability of IMR stock?

IMETAL RESOURCES INC (IMR.CA) has a profitability rating of 1 / 10.


How financially healthy is IMETAL RESOURCES INC?

The financial health rating of IMETAL RESOURCES INC (IMR.CA) is 5 / 10.